Avapritinib and its Impurities

Avapritinib, sold under the brand name Ayvakit. it is a selective tyrosine kinase inhibitor being investigated for the treatment of multidrug resistant gastrointestinal tumors. Reference standards of Avapritinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 13 results for Avapritinib Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 01 3920000

Avapritinib

Avapritinib


  • Catalogue No.:PA 01 3920000

  • CAS :

    1703793-34-3

  • Molecular Formula : C26H27FN10

  • Molecular Weight : 498.57

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921000

4-(4-(5-(1-(4-Fluorophenyl)vinyl)pyrimidin-2-yl)piperazin-1-yl)-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine

4-(4-(5-(1-(4-Fluorophenyl)vinyl)pyrimidin-2-yl)piperazin-1-yl)-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine


  • Catalogue No.:PA 01 3921000

  • CAS :

    1703793-09-2

  • Molecular Formula : C26H24FN9

  • Molecular Weight : 481.54

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921001

(S)-1-(2-(4-(6-Bromopyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)-1-(4-fluorophenyl)ethan-1-amine

(S)-1-(2-(4-(6-Bromopyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)-1-(4-fluorophenyl)ethan-1-amine


  • Catalogue No.:PA 01 3921001

  • CAS :

    2505078-30-6

  • Molecular Formula : C22H22BrFN8

  • Molecular Weight : 497.38

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921002

(R)-1-(4-Fluorophenyl)-1-(2-(piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine

(R)-1-(4-Fluorophenyl)-1-(2-(piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine


  • Catalogue No.:PA 01 3921002

  • CAS :

    1704492-16-9

  • Molecular Formula : C16H20FN5

  • Molecular Weight : 301.37

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921003

R-Avapritinib

R-Avapritinib


  • Catalogue No.:PA 01 3921003

  • CAS :

    1703793-32-1

  • Molecular Formula : C26H27FN10

  • Molecular Weight : 498.57

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921004

(S)-N-(1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethyl)hydroxylamine

(S)-N-(1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethyl)hydroxylamine


  • Catalogue No.:PA 01 3921004

  • CAS :

    NA

  • Molecular Formula : C26H27FN10O

  • Molecular Weight : 514.57

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921005

(2R,3R,4R,5S,6R)-6-((((S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethyl)amino)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid

(2R,3R,4R,5S,6R)-6-((((S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethyl)amino)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid


  • Catalogue No.:PA 01 3921005

  • CAS :

    NA

  • Molecular Formula : C32H35FN10O7

  • Molecular Weight : 690.69

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921006

4-(4-(5-(2-(4-Fluorophenyl)propan-2-yl)pyrimidin-2-yl)piperazin-1-yl)-7-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a][1,3,5]triazine

4-(4-(5-(2-(4-Fluorophenyl)propan-2-yl)pyrimidin-2-yl)piperazin-1-yl)-7-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a][1,3,5]triazine


  • Catalogue No.:PA 01 3921006

  • CAS :

    1703793-31-0

  • Molecular Formula : C26H27FN10

  • Molecular Weight : 498.57

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921007

(2-(4-(6-(4-Fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)(phenyl)methanone

(2-(4-(6-(4-Fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)(phenyl)methanone


  • Catalogue No.:PA 01 3921007

  • CAS :

    1703795-41-8

  • Molecular Formula : C27H22FN7O

  • Molecular Weight : 479.52

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921008

(R)-(4-Fluorophenyl)(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)methanol

(R)-(4-Fluorophenyl)(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)methanol


  • Catalogue No.:PA 01 3921008

  • CAS :

    1703793-18-3

  • Molecular Formula : C25H24FN9O

  • Molecular Weight : 485.53

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921009

6-(1-Methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one

6-(1-Methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one


  • Catalogue No.:PA 01 3921009

  • CAS :

    1703794-32-4

  • Molecular Formula : C10H9N5O

  • Molecular Weight : 215.22

Drug Reference Standards & Impurity Synthesis in India
PA 01 3921010

Methyl 1-amino-4-bromo-1H-pyrrole-2-carboxylate

Methyl 1-amino-4-bromo-1H-pyrrole-2-carboxylate


  • Catalogue No.:PA 01 3921010

  • CAS :

    1208361-39-0

  • Molecular Formula : C6H7BrN2O2

  • Molecular Weight : 219.04

Drug Reference Standards & Impurity Synthesis in India
PA STI 090229

Avapritinib Tetrahydrochloride 13CD3

Avapritinib Tetrahydrochloride 13CD3


  • Catalogue No.:PA STI 090229

  • CAS :

    NA

  • Molecular Formula : C2513CH28D3Cl4FN10

  • Molecular Weight : 648.41